Labetuzumab govitecan

Labetuzumab govitecan (IMMU-135) is an anti- CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule) antibody-drug conjugate (ADC). Labetuzumab govitecan is composed of an anti– CEACAM5 antibody, a pH-sensitive Linker, a cytotoxic agent SN38. This product is for research use only. Labetuzumab govitecan has an approximate molecular weight of 154 kDa. This product is for research use only.

Product Details
Species Reactivity	Human
Type	Antibody-drug conjugate
ADC antibody	Labetuzumab (anti-CEACAM5)
ADC cytotoxin (drug)	SN-38
Immunogen	Human CEACAM5
DAR (Drug to Antibody Ratio)	N/A
Purity	99%
Molecular Weight	154kDa
Storage Condition	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Storage Buffer	1xPBS